Panagiotis Kanellopoulos

[99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes

Berthold A. Nock, Aikaterini Kaloudi, Panagiotis Kanellopoulos et al. · Cancers · 2021 · 33 citations · Full text

One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [99mTc]Tc-DB4 and [111In]In-SG4 in Mice Treated with Entresto

Panagiotis Kanellopoulos, Aikaterini Kaloudi, Maritina Rouchota et al. · Pharmaceutics · 2020 · 19 citations · Full text

Comparative evaluation of the new GRPR‐antagonist ¹¹¹In‐SB9 and ¹¹¹In‐AMBA in prostate cancer models: Implications of in vivo stability

Emmanouil Lymperis, Aikaterini Kaloudi, Panagiotis Kanellopoulos et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2019 · 15 citations

Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair

Emmanouil Lymperis, Aikaterini Kaloudi, Panagiotis Kanellopoulos et al. · Molecules · 2019 · 14 citations · Full text

Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands

Panagiotis Kanellopoulos, Aikaterini Kaloudi, Marion de Jong et al. · Pharmaceutics · 2020 · 12 citations · Full text